Anthropometry (1)
- BMI - Body mass index (phv00396130.v1.p1)
Demographics (1)
- GENDER - Sex of subject (phv00396124.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Is subject affected with hepatocellular carcinoma (phv00347692.v1.p1)
- AFP - Serum alpha-fetoprotein level (phv00396129.v1.p1)
- DM - Diabetes mellitus type (phv00396131.v1.p1)
- HTN - Hypertension (phv00396132.v1.p1)
- LIVER DISEASE - Underlying liver disease (phv00396128.v1.p1)
Race and Ethnicity (1)
- RACE - Race of subject (phv00396125.v1.p1)
Other (23)
- ANALYTE_TYPE - Analyte type (phv00347698.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00347697.v1.p1)
- CIRRHOSIS - Presence of cirrhosis (phv00396126.v1.p1)
- CONSENT - Allowable research use (phv00347691.v1.p1)
- ETOH - Alcoholic liver disease (phv00396133.v1.p1)
- Group - Sequencing group (phv00396123.v1.p1)
- HCC Recurrence - Presence or absence of disease recurrence (phv00396138.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00347699.v1.p1)
- IS_TUMOR - Tumor status (phv00347700.v1.p1)
- LVSI - Lymph vascular space invasion (phv00396137.v1.p1)
- MGI_SAMPLE_ID - In-house sample identifier (phv00347701.v1.p1)
- MONTHS FOLLOWUP - Months to first follow-up (phv00396140.v1.p1)
- MONTHS TO DEATH - Months from admission to death (phv00396141.v1.p1)
- MONTHS TO RECURRENCE - Months from admission to recurrence (phv00396139.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00347696.v1.p1)
- SAMPLE_ID - Sample ID (phv00347694.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00396122.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00347690.v1.p1)
- SUBJECT_ID - Subject ID (phv00347693.v1.p1)
- TREATMENT - Course of treatment (phv00396127.v1.p1)
- TUMOR DIFFERENTIATION - Differentiation of the tumor cells (phv00396136.v1.p1)
- TUMOR NUMBER - Number of tumors (phv00396135.v1.p1)
- TUMOR SIZE - Size of tumor (phv00396134.v1.p1)